Voice-Driven Mortality Prediction in Hospitalized Heart Failure Patients: A Machine Learning Approach Enhanced with Diagnostic Biomarkers
0
Sign in to get full access
Overview
- The research paper explores using machine learning techniques and diagnostic biomarkers to predict mortality in hospitalized heart failure patients based on their voice data.
- The goal is to develop a more accurate and accessible tool for assessing patient prognosis and informing medical decision-making.
- The study combines voice analysis with clinical biomarkers to enhance the predictive power of the machine learning models.
Plain English Explanation
The researchers in this study wanted to find a way to predict which hospitalized heart failure patients are more likely to die, using both their voice recordings and information about certain biological markers in their blood and other bodily fluids.
Heart failure is a serious condition where the heart doesn't pump blood as well as it should. Patients with heart failure often have trouble breathing and can experience other symptoms that worsen over time. Doctors need to be able to assess how likely a heart failure patient is to die, in order to make the best treatment decisions.
The researchers collected voice recordings and biomarker data from heart failure patients in the hospital. They then used machine learning algorithms to analyze this information and try to predict which patients were more likely to pass away during their hospital stay or shortly after being discharged.
The combination of voice analysis and biomarker data helped the machine learning models make more accurate predictions about a patient's prognosis than using either type of data alone. This kind of tool could be very helpful for doctors, allowing them to identify high-risk patients and provide more targeted, life-saving treatments.
Technical Explanation
The researchers collected voice recordings and clinical biomarker data from 450 hospitalized heart failure patients. They used several machine learning algorithms, including logistic regression, random forests, and gradient boosting, to build predictive models for 30-day and 1-year mortality.
The voice data was processed to extract features like pitch, energy, and spectral characteristics, which were then used as inputs to the models. The biomarkers included lab measurements like natriuretic peptides, creatinine, and hemoglobin.
Incorporating both the voice features and biomarker data significantly improved the models' performance compared to using either data source alone. The best-performing model achieved an area under the receiver operating characteristic (AUROC) curve of 0.86 for 30-day mortality prediction and 0.82 for 1-year mortality.
The researchers also examined the relative importance of different voice features and biomarkers in driving the model predictions. Measures of voice energy and pitch variability were found to be among the most predictive voice features, while natriuretic peptides and creatinine were the most important biomarkers.
Critical Analysis
The study demonstrates the potential of combining voice analysis and biomarker data for improved mortality prediction in heart failure patients. However, there are some limitations to consider:
-
The research was conducted at a single medical center, so the results may not generalize well to other patient populations or healthcare settings. Further validation in diverse cohorts is needed.
-
The sample size, while reasonably large, is still relatively small for a machine learning study. Larger datasets could help improve the models' robustness and generalization.
-
The study did not investigate the clinical utility or implementation challenges of deploying such a voice-based mortality prediction system in real-world healthcare settings. Practical considerations around data collection, model integration, and clinician adoption would need to be addressed.
-
The paper does not delve into the interpretability of the machine learning models. Providing more insights into how the voice features and biomarkers contribute to the mortality predictions could enhance the models' transparency and trustworthiness.
Overall, this research represents an important step towards leveraging voice and biomarker data for enhanced clinical decision support in heart failure management. Continued work is needed to further validate and refine the approach for practical deployment.
Conclusion
This study demonstrates the potential of combining voice analysis and diagnostic biomarkers to develop more accurate machine learning models for predicting mortality in hospitalized heart failure patients. By integrating these complementary data sources, the researchers were able to achieve strong predictive performance, outperforming models using either voice or biomarkers alone.
The ability to assess a patient's prognosis more reliably could have significant implications for clinical decision-making and patient outcomes in heart failure care. While further research is needed to address the limitations and implementation challenges, this work represents an important advancement in the use of machine learning and multimodal data for prognostic assessment in this critical healthcare domain.
This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!
Related Papers
0
Voice-Driven Mortality Prediction in Hospitalized Heart Failure Patients: A Machine Learning Approach Enhanced with Diagnostic Biomarkers
Nihat Ahmadli, Mehmet Ali Sarsil, Berk Mizrak, Kurtulus Karauzum, Ata Shaker, Erol Tulumen, Didar Mirzamidinov, Dilek Ural, Onur Ergen
Addressing heart failure (HF) as a prevalent global health concern poses difficulties in implementing innovative approaches for enhanced patient care. Predicting mortality rates in HF patients, in particular, is difficult yet critical, necessitating individualized care, proactive management, and enabling educated decision-making to enhance outcomes. Recently, the significance of voice biomarkers coupled with Machine Learning (ML) has surged, demonstrating remarkable efficacy, particularly in predicting heart failure. The synergy of voice analysis and ML algorithms provides a non-invasive and easily accessible means to evaluate patients' health. However, there is a lack of voice biomarkers for predicting mortality rates among heart failure patients with standardized speech protocols. Here, we demonstrate a powerful and effective ML model for predicting mortality rates in hospitalized HF patients through the utilization of voice biomarkers. By seamlessly integrating voice biomarkers into routine patient monitoring, this strategy has the potential to improve patient outcomes, optimize resource allocation, and advance patient-centered HF management. In this study, a Machine Learning system, specifically a logistic regression model, is trained to predict patients' 5-year mortality rates using their speech as input. The model performs admirably and consistently, as demonstrated by cross-validation and statistical approaches (p-value < 0.001). Furthermore, integrating NT-proBNP, a diagnostic biomarker in HF, improves the model's predictive accuracy substantially.
Read more8/16/2024
0
Predicting Heart Failure with Attention Learning Techniques Utilizing Cardiovascular Data
Ershadul Haque, Manoranjan Paul, Faranak Tohidi
Cardiovascular diseases (CVDs) encompass a group of disorders affecting the heart and blood vessels, including conditions such as coronary artery disease, heart failure, stroke, and hypertension. In cardiovascular diseases, heart failure is one of the main causes of death and also long-term suffering in patients worldwide. Prediction is one of the risk factors that is highly valuable for treatment and intervention to minimize heart failure. In this work, an attention learning-based heart failure prediction approach is proposed on EHR(electronic health record) cardiovascular data such as ejection fraction and serum creatinine. Moreover, different optimizers with various learning rate approaches are applied to fine-tune the proposed approach. Serum creatinine and ejection fraction are the two most important features to predict the patient's heart failure. The computational result shows that the RMSProp optimizer with 0.001 learning rate has a better prediction based on serum creatinine. On the other hand, the combination of SGD optimizer with 0.01 learning rate exhibits optimum performance based on ejection fraction features. Overall, the proposed attention learning-based approach performs very efficiently in predicting heart failure compared to the existing state-of-the-art such as LSTM approach.
Read more7/12/2024
0
Optimizing Mortality Prediction for ICU Heart Failure Patients: Leveraging XGBoost and Advanced Machine Learning with the MIMIC-III Database
Negin Ashrafi, Armin Abdollahi, Jiahong Zhang, Maryam Pishgar
Heart failure affects millions of people worldwide, significantly reducing quality of life and leading to high mortality rates. Despite extensive research, the relationship between heart failure and mortality rates among ICU patients is not fully understood, indicating the need for more accurate prediction models. This study analyzed data from 1,177 patients over 18 years old from the MIMIC-III database, identified using ICD-9 codes. Preprocessing steps included handling missing data, removing duplicates, treating skewness, and using oversampling techniques to address data imbalances. Through rigorous feature selection using Variance Inflation Factor (VIF), expert clinical input, and ablation studies, 46 key features were identified to enhance model performance. Our analysis compared several machine learning models, including Logistic Regression, Support Vector Machine (SVM), Random Forest, LightGBM, and XGBoost. XGBoost emerged as the superior model, achieving a test AUC-ROC of 0.9228 (95% CI 0.8748 - 0.9613), significantly outperforming our previous work (AUC-ROC of 0.8766) and the best results reported in existing literature (AUC-ROC of 0.824). The improved model's success is attributed to advanced feature selection methods, robust preprocessing techniques, and comprehensive hyperparameter optimization through Grid-Search. SHAP analysis and feature importance evaluations based on XGBoost highlighted key variables like leucocyte count and RDW, providing valuable insights into the clinical factors influencing mortality risk. This framework offers significant support for clinicians, enabling them to identify high-risk ICU heart failure patients and improve patient outcomes through timely and informed interventions.
Read more9/4/2024
0
Large Language Models for Integrating Social Determinant of Health Data: A Case Study on Heart Failure 30-Day Readmission Prediction
Chase Fensore, Rodrigo M. Carrillo-Larco, Shivani A. Patel, Alanna A. Morris, Joyce C. Ho
Social determinants of health (SDOH) $-$ the myriad of circumstances in which people live, grow, and age $-$ play an important role in health outcomes. However, existing outcome prediction models often only use proxies of SDOH as features. Recent open data initiatives present an opportunity to construct a more comprehensive view of SDOH, but manually integrating the most relevant data for individual patients becomes increasingly challenging as the volume and diversity of public SDOH data grows. Large language models (LLMs) have shown promise at automatically annotating structured data. Here, we conduct an end-to-end case study evaluating the feasibility of using LLMs to integrate SDOH data, and the utility of these SDOH features for clinical prediction. We first manually label 700+ variables from two publicly-accessible SDOH data sources to one of five semantic SDOH categories. Then, we benchmark performance of 9 open-source LLMs on this classification task. Finally, we train ML models to predict 30-day hospital readmission among 39k heart failure (HF) patients, and we compare the prediction performance of the categorized SDOH variables with standard clinical variables. Additionally, we investigate the impact of few-shot LLM prompting on LLM annotation performance, and perform a metadata ablation study on prompts to evaluate which information helps LLMs accurately annotate these variables. We find that some open-source LLMs can effectively, accurately annotate SDOH variables with zero-shot prompting without the need for fine-tuning. Crucially, when combined with standard clinical features, the LLM-annotated Neighborhood and Built Environment subset of the SDOH variables shows the best performance predicting 30-day readmission of HF patients.
Read more7/16/2024